Eternity Bioscience, Inc.

A high performance team dedicated to discovering novel and life-saving drugs


Our Mission
was founded in 2009 by Hengrui USA, the US subsidiary of a well-established and innovative pharmaceutical company in China, Jiangsu Hengrui Medicine. Our mission is to deliver high value drug candidates for critical medical needs with first- or best-in-class (FIC/BIC) potential in a highly translational, timely and cost-efficient fashion. For all the preclinical drug candidates we discover, Jiangsu Hengrui Medicine will gain worldwide development and marketing rights. 

Our Vision

Our vision is to accomplish the mission by leveraging our core expertise in translational drug discovery research and discovering new chemical entities with differentiated FIC/BIC drug attributesSince 2010, we have built an outstanding international team of scientists based in the US and China to conduct drug discovery research on targeted cancer therapeutics and have delivered a number of preclinical candidates that are entering clinical studies. With site expansion since 2017, we envision becoming a top-notch team that will have transformed both the art of drug discovery and the landscape of human disease management.

  Our Core Values

Excellent science
Translational discovery
Efficient execution
Respectful to each other
No nonsense with integrity
Innovative all the time
Timely delivery on goals
Yielding high value drugs